Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Decode Cure has developed CE-marked and certified diagnostic solutions that combine advanced gene sequencing with proprietary bioinformatics to rapidly detect pathogens in clinical samples. Their technology reportedly reduces time-to-result by up to ten days compared to standard clinical workflows. Products are used in both clinical and non-clinical settings, with a focus on improving accuracy and efficiency in infectious disease diagnosis. Clinical results indicate faster turnaround times while maintaining high accuracy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Decode Cure Limited.